TrialCardiovascular diabetology2023
Left ventricular mass predicts cardiac reverse remodelling in patients treated with empagliflozin.
Pankaj Puar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it